OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Psychoactive Drugs is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies	34
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health	28
Prevalence and Correlates of GHB Use among Adults in the United States	23
Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool	19
Pathways to Peer Support in Sober Living Houses: The Importance of Social Model Environments and Helping Behaviors	17
Methamphetamine-Induced Wakefulness and Sleep Management: A Qualitative Analysis of Online Narratives	16
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey	16
A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers	16
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–2020	16
Selection Bias in Psychedelic Research: Comparing Self-Reported Quality-Of-Life Impact Between Enthusiasts and a General Population Sample	15
Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence	14
Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine	14
Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency	13
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders	13
Construction and Standardization of Perceived Shame Scale for Young Adults with Paternal Substance Use Disorder in Pakistan	13
The Epidemiology of Psychedelic Use Among United States Military Veterans	13
Prescription and Non-Prescription Anxiolytic Use is Linked to Personal Characteristics Among University Students	12
Suicide Attempts in an Italian Population with Cannabis Use Disorders: Results of a Follow-Up Study	12
Religious Social Integration, Psychedelics, and Psychological Distress	12
Religion, Psychedelics, Risky Behavior, and Violence	12
Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context	11
“It’s so Natural It Goes Hand in Hand”: A Qualitative Study of Maternal Perceptions of Cannabis Use during Pregnancy	11
Comparison of Emotional Processing Between Patients with Substance Use Disorder and Those with Dual Diagnosis: Relationship with Severity of Dependence and Use During Treatment	11
Naturalistic Psychedelic Use: A World Apart from Clinical Care	11
Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use	10

Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms	10
Interactions Between Depressive Symptoms, Childhood Trauma, and Drug Craving in Chinese Men with Methamphetamine Use Disorder: A Network Analysis	10
A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients’ Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand	10
Psychedelic Microdosing among Young Adults from Southern California	10
Role Strain Among Parents Who are Medical Cannabis Patients in Pennsylvania	10
Effect of Social Vulnerability on Cocaine-Related Mortality Rates in U.S. Counties	9
Not Losing Momentum: Cross-Sectional Insights into Ibogaine Clinical Trials	9
From Policy to Perception: Do Public Views on UK Drug Policy Shape Attitudes Toward Psychedelics?	9
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use	9
Cortisol/DHEA-S Ratio Normalization by Buprenorphine: Associations with Stress, Coping, and Social Support in Youth with Opioid Use Disorder	9
Self-Forgiveness and Gratitude in Recovery from Substance Use Disorders	9
Psychedelic Use and Behavioral Addictions	9
Minor Cannabinoid Use Among Medical Cannabis Patients	9
Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge	8
Delta-8- and Delta-9-THC Use Frequency, Use Motives, and Mental Health Outcomes	8
State-Level Support for Recovery Housing: Results from a National Collaborative Study of U.S. Single State Agencies	8
Smoking Behavior and Wellness among Individuals in Substance Use Disorder Treatment	8
Ayahuasca Therapy: Possible Reduction of Suicidal Ideation in Treatment-Resistant Depression – A Systematic Review	8
“Spice Was Made, by the Devil Himself”: A Thematic Analysis of the Experience of an Addiction to Synthetic Cannabinoids	8
The Protective Role of Savoring on Coping Motives for Cannabis Use and Consequences	8
Solitary Cannabis Use and Related Consequences Among College Students During the COVID-19 Pandemic	8
The Relationship Between Alcohol Use, Blood Alcohol Concentration, and Road Traffic Accidents: A Scoping Review	8
Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset	8
N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)	7
Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review	7
Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study	7
Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress	7
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study	7
Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay	6
Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?	6
Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products	6
Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy	6
Cannabis Expectancies for Sleep Modulate Discrepancies Between Subjective and Objective Sleep Outcomes: A Pilot Study	6
Examining Volunteer Bias in Psychedelic Research	6
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences	6
Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals	6
MDMA-Assisted Psychotherapy for PTSD: A Systematic Review of Randomized Control Trials	6
Approach Without Liking: The Effects of Smoking-Related Settings on Implicit Liking Attitudes and Approach Tendencies Toward Smoking	6
Public Knowledge, Perceptions, and Behavioral Intention Regarding Medical Cannabis in Belgium	6
Opioid Use Disorder and COVID-19: Treatment and Recovery Factors among Vulnerable Populations at the Intersection of Two U.S. Epidemics	6
Kratom Retail Availability in Fort Worth, Texas	6
Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT)	6
Outcomes Among Sober Living House Residents Who Relapse: Role of Recovery Capital	6
What Differentiates Dropping Out from Remaining in a Brief Intervention for Problematic and Dependent Methamphetamine Users?	6
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption	5
Identification of Cannabis Product Characteristics and Pricing on Dark Web Markets	5
Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico	5
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts	5
Death Anxiety Among Users and Non-Users of Psychedelics	5
Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review	5

Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine	5
“How Do I Learn More About this?”: Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics	5
The Association of Substance Use Disorder (SUD) Type and Other Factors in SUD Recognition Among U.S. Adults	5
How Personal Attitudes About Legalizing Cannabis and Corresponding State Laws Affect the Stigma of Cannabis Use	5
Cannabis Dependence Among Georgian Small-Scale Cannabis Growers: Results of a Cross-Sectional Online Survey	5
Economic Stress, Mental Health, and Drug Use: Regional Insights from Taiwan	5